USPTO serial 79332167
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angel Miguel Munoz, Esq.
Angel Miguel Munoz, Esq. Munoz-Lopez & Associates PLLC305 BroadwaySuite 704New York, NY 10007| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in pharmaceutical product manufacture; chemical additives for use in the manufacture of pharmaceuticals; chemical products for manufacturing cosmetics; chemical products for use in industry | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune-related diseases and disorders; sanitary sterilizing preparations; dietetic foods adapted for medical use; probiotic supplements; food supplements for persons; disinfectants; preparations for destroying vermin; fungicides; antiseptic preparations; food for babies; medical and surgical plasters; surgical dressings; teeth filling and dental impression materials; herbicides | ACTIVE | — |
| 010 | Medical instruments for use in surgery; orthopedic walkers; suture materials | ACTIVE | — |
| 042 | Evaluation of pharmaceutical products; pharmaceutical research services; pharmaceutical research and development; inspection of pharmaceutical products; research relating to pharmaceutical products; clinical studies for pharmaceutical products; development of pharmaceutical products; scientific research relating to social medicine; research and development of vaccines and medicines; services for assessing the effectiveness of veterinary medicines | ACTIVE | — |
| 044 | Pharmaceutical advice; pharmaceutical dispensary services; dispensing of medicines; provision of information relating to medicine | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 14, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 14, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 13, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 18, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 13, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 13, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 8, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 28, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 7, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 7, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 24, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 23, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2022 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Feb 8, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 3, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |